Co-Diagnostics (NASDAQ:CODX) announces a
surge in domestic and international demand for its CE-IVD Logix Smart
COVID-19 Test Kit subsequent to the change in FDA policy allowing
laboratories to assay samples after validating the test in-house before
formal FDA Emergency Use Authorization.
Selected coronavirus-related tickers: iBio (NYSEMKT:IBIO) (+31%), Alpha Pro Tech (NYSEMKT:APT) (+13%), Novavax (NASDAQ:NVAX) (+9%), Vaxart (NASDAQ:VXRT) (+7%), Lakeland Industries (NASDAQ:LAKE) (+5%), Inovio Pharmaceuticals (NASDAQ:INO) (+5%)
https://seekingalpha.com/news/3548928-co-diagnostics-up-23-premarket-on-strong-demand-for-coronavirus-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.